Passa al contenuto
Merck

Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα-mediated lipid metabolism.

The Journal of clinical investigation (2020-03-24)
Xin Zhou, Chenxi He, Jiangong Ren, Congxin Dai, Sharon R Stevens, Qianghu Wang, Daniel Zamler, Takashi Shingu, Liang Yuan, Chythra R Chandregowda, Yunfei Wang, Visweswaran Ravikumar, Arvind Uk Rao, Feng Zhou, Hongwu Zheng, Matthew N Rasband, Yiwen Chen, Fei Lan, Amy B Heimberger, Benjamin M Segal, Jian Hu
ABSTRACT

Lipid-rich myelin forms electrically insulating, axon-wrapping multilayers that are essential for neural function, and mature myelin is traditionally considered metabolically inert. Surprisingly, we discovered that mature myelin lipids undergo rapid turnover, and quaking (Qki) is a major regulator of myelin lipid homeostasis. Oligodendrocyte-specific Qki depletion, without affecting oligodendrocyte survival, resulted in rapid demyelination, within 1 week, and gradually neurological deficits in adult mice. Myelin lipids, especially the monounsaturated fatty acids and very-long-chain fatty acids, were dramatically reduced by Qki depletion, whereas the major myelin proteins remained intact, and the demyelinating phenotypes of Qki-depleted mice were alleviated by a high-fat diet. Mechanistically, Qki serves as a coactivator of the PPARβ-RXRα complex, which controls the transcription of lipid-metabolism genes, particularly those involved in fatty acid desaturation and elongation. Treatment of Qki-depleted mice with PPARβ/RXR agonists significantly alleviated neurological disability and extended survival durations. Furthermore, a subset of lesions from patients with primary progressive multiple sclerosis were characterized by preferential reductions in myelin lipid contents, activities of various lipid metabolism pathways, and expression level of QKI-5 in human oligodendrocytes. Together, our results demonstrate that continuous lipid synthesis is indispensable for mature myelin maintenance and highlight an underappreciated role of lipid metabolism in demyelinating diseases.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Sigma-Aldrich
Anticorpo anti-Olig-2, Chemicon®, from rabbit
Sigma-Aldrich
Anticorpo anti-Olig2, clone 211F1.1, clone 211F1.1, from mouse
Sigma-Aldrich
Anticorpo anti-Aspa/Nur7, from rabbit, purified by affinity chromatography
Sigma-Aldrich
Anticorpo anti-proteina basica della mielina, serum, Chemicon®
Sigma-Aldrich
Bexarotene, ≥98% (HPLC)
Sigma-Aldrich
Monoclonal Anti-Qki (Pan) antibody produced in mouse, clone S147-6, purified immunoglobulin